Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Epilepsy Society is the United Kingdom's leading charity for epilepsy, providing a unique combination of specialist medical care, residential services, and pioneering research. Based at the Chalfont Centre for Epilepsy, the organization operates in close partnership with University College London (UCL) to conduct world-class genomic and neuroimaging research aimed at personalizing epilepsy treatment. Their facilities include a dedicated MRI unit and clinical assessment services that support the NHS in diagnosing complex cases. Beyond research and clinical care, the Society provides extensive patient support through a national helpline, information resources, and advocacy initiatives. The organization is a key player in the global effort to understand the genetic basis of epilepsy and improve therapeutic outcomes through precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epilepsy Society.